Amgen (AMGN) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.
- Amgen's Income from Continuing Operations rose 11259.97% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.7 billion, marking a year-over-year increase of 8853.3%. This contributed to the annual value of $7.7 billion for FY2025, which is 8853.3% up from last year.
- Latest data reveals that Amgen reported Income from Continuing Operations of $1.3 billion as of Q4 2025, which was up 11259.97% from $3.2 billion recorded in Q3 2025.
- Over the past 5 years, Amgen's Income from Continuing Operations peaked at $3.2 billion during Q3 2025, and registered a low of -$113.0 million during Q1 2024.
- In the last 5 years, Amgen's Income from Continuing Operations had a median value of $1.5 billion in 2022 and averaged $1.5 billion.
- Per our database at Business Quant, Amgen's Income from Continuing Operations crashed by 10397.75% in 2024 and then skyrocketed by 163097.35% in 2025.
- Over the past 5 years, Amgen's Income from Continuing Operations (Quarter) stood at $1.9 billion in 2021, then fell by 14.9% to $1.6 billion in 2022, then tumbled by 52.54% to $767.0 million in 2023, then dropped by 18.25% to $627.0 million in 2024, then skyrocketed by 112.6% to $1.3 billion in 2025.
- Its Income from Continuing Operations stands at $1.3 billion for Q4 2025, versus $3.2 billion for Q3 2025 and $1.4 billion for Q2 2025.